Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Brimonidine Tartrate Eye Drops

Approval Number

国药准字HJ20160681

CompanyAbbVie Limited

Registration Date

June 28, 2021

Previous Approval Numbers

H20160681

Drug Information

Generic Name

酒石酸溴莫尼定滴眼液

Trade Name

阿法根

Dosage Form

眼用制剂

Strength

5ml:10mg

Drug Type

化学药品

Registration Date

June 28, 2021

Expiry Date

June 27, 2026

Company Information

Applicant Company

Company NameAbbVie Limited

Company Address

Citywest Business Campus，Dublin 24，Ireland

Manufacturing Company

Company NameAllergan Pharmaceuticals Ireland

Company Address

Castlebar Road, Westport, County Mayo, Ireland

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

酒石酸溴莫尼定滴眼液 - NMPA 批准文号 | MedPath